 VANCOUVER, British Columbia-- BUSINESS WIRE --Zymeworks Inc. Nasdaq: ZYME, a clinical-stage biotechnology company developing novel, multifunctional biotherapeutics, today announced that management will participate in an upcoming investor conference: 